Skip to main content

Table 2 Percentage of tick-free primary dogs (dogs with ≥ 4 ticks on day 0)

From: Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions

Visit (study day)

Tick-free dogs

P-value

Lower 97.5% one-sided confidence interval

Fluralaner injection (n = 164)

Afoxolaner oral (n = 72)

 

2 (14)

158 (96.3%)

69 (95.8%)

 < 0.0001

−0.0514

3 (28)

161 (98.2%)

69 (95.8%)

 < 0.0001

−0.0319

4 (56)

158 (96.9%)a

69 (95.8%)

 < 0.0001

−0.0452

5 (84)

163 (99.4%)

72 (100.0%)

 < 0.0001

−0.0520

6 (112)

164 (100.0%)

71 (98.6%)

 < 0.0001

−0.0350

7 (224)

164 (100.0%)

72 (100.0%)

Statistical test not possible

8 (280)

163 (99.4%)

70 (97.2%)

 < 0.0001

−0.0302

9 (336)

157 (95.7%)

71 (98.6%)

0.0026

−0.0788

10 (365)

160 (97.6%)

70 (97.2%)

 < 0.0001

−0.0493

  1. a Assessment from 163 dogs